RAPT Therapeutics, Inc. Share Price
RAPTRAPT Therapeutics, Inc. Stock Performance
Open $30.17 | Prev. Close $31.05 | Circuit Range N/A |
Day Range $30.17 - $31.50 | Year Range $5.67 - $42.09 | Volume 8,661 |
Average Traded $31.02 |
RAPT Therapeutics, Inc. Share Price Chart
About RAPT Therapeutics, Inc.
RAPT Therapeutics, Inc. operates as a clinical-stage immunology-based biopharmaceutical company that focuses on the discovery, development, and commercialization of oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases in the United States. The company's lead inflammation drug candidate is zelnecirnon (RPT193), a C-C motif chemokine receptor 4 (CCR4) antagonist that selectively inhibit the migration of type 2 T helper cells into inflamed tissues. Its lead oncology drug candidate is tivumecirnon (FLX475), an oral small molecule CCR4 antagonist that is in the Phase 1/2 clinical trial to investigate as a monotherapy and in combination with pembrolizumab in patients with advanced cancer. The company was formerly known as FLX Bio, Inc. and changed its name to RAPT Therapeutics, Inc. in May 2019. RAPT Therapeutics, Inc. was incorporated in 2015 and is based in South San Francisco, California.
RAPT Therapeutics, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
06-Jan-26 | $30.17 | $30.86 | +0.00% |
06-Jan-26 | $30.17 | $30.86 | +3.28% |
05-Jan-26 | $32.00 | $29.88 | -6.10% |
02-Jan-26 | $33.80 | $31.82 | -5.98% |
31-Dec-25 | $33.78 | $33.84 | +1.20% |
30-Dec-25 | $35.51 | $33.45 | -6.80% |
29-Dec-25 | $35.31 | $35.88 | +1.31% |
FAQs on RAPT Therapeutics, Inc. Share Price
Can I buy RAPT Therapeutics, Inc. shares in India?
What is the share price of RAPT Therapeutics, Inc.?
What is the 5 year returns of RAPT Therapeutics, Inc.?
What are the high & low stock price of RAPT Therapeutics, Inc. today?
What is the 52-week high and low of RAPT Therapeutics, Inc. stock?